# Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma

**Authors:** Raphaella Lambert, Scott Stratman, Grace Rabinowitz, Hannah Verma, Jonas A. Adalsteinsson, George Niedt, Benjamin Ungar, Nicholas Gulati

PMC · DOI: 10.1016/j.jdcr.2024.12.030 · JAAD Case Reports · 2025-01-15

## Full-text entities

- **Diseases:** dyshidrotic eczema (MESH:D011146), hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** tremelimumab (MESH:C520704)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11993177/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11993177/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC11993177/full.md

---
Source: https://tomesphere.com/paper/PMC11993177